Progyny Statistics
Total Valuation
Progyny has a market cap or net worth of $1.92 billion. The enterprise value is $1.71 billion.
| Market Cap | 1.92B |
| Enterprise Value | 1.71B |
Important Dates
The next estimated earnings date is Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Progyny has 76.73 million shares outstanding. The number of shares has decreased by -4.01% in one year.
| Current Share Class | 76.73M |
| Shares Outstanding | 76.73M |
| Shares Change (YoY) | -4.01% |
| Shares Change (QoQ) | -3.08% |
| Owned by Insiders (%) | 1.81% |
| Owned by Institutions (%) | 104.02% |
| Float | 70.23M |
Valuation Ratios
The trailing PE ratio is 27.59 and the forward PE ratio is 11.48. Progyny's PEG ratio is 1.00.
| PE Ratio | 27.59 |
| Forward PE | 11.48 |
| PS Ratio | 1.48 |
| Forward PS | 1.35 |
| PB Ratio | 4.27 |
| P/TBV Ratio | 4.52 |
| P/FCF Ratio | 10.84 |
| P/OCF Ratio | 9.61 |
| PEG Ratio | 1.00 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.73, with an EV/FCF ratio of 9.66.
| EV / Earnings | 21.92 |
| EV / Sales | 1.32 |
| EV / EBITDA | 13.73 |
| EV / EBIT | 14.39 |
| EV / FCF | 9.66 |
Financial Position
The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.14 |
| Quick Ratio | 2.06 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.21 |
| Debt / FCF | 0.15 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 16.24% and return on invested capital (ROIC) is 32.44%.
| Return on Equity (ROE) | 16.24% |
| Return on Assets (ROA) | 10.14% |
| Return on Invested Capital (ROIC) | 32.44% |
| Return on Capital Employed (ROCE) | 25.19% |
| Weighted Average Cost of Capital (WACC) | 9.57% |
| Revenue Per Employee | $1.53M |
| Profits Per Employee | $91,861 |
| Employee Count | 856 |
| Asset Turnover | 1.78 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Progyny has paid $41.21 million in taxes.
| Income Tax | 41.21M |
| Effective Tax Rate | 34.38% |
Stock Price Statistics
The stock price has increased by +16.75% in the last 52 weeks. The beta is 0.99, so Progyny's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | +16.75% |
| 50-Day Moving Average | 27.35 |
| 200-Day Moving Average | 24.21 |
| Relative Strength Index (RSI) | 37.22 |
| Average Volume (20 Days) | 1,091,835 |
Short Selling Information
The latest short interest is 4.71 million, so 6.14% of the outstanding shares have been sold short.
| Short Interest | 4.71M |
| Short Previous Month | 4.45M |
| Short % of Shares Out | 6.14% |
| Short % of Float | 6.70% |
| Short Ratio (days to cover) | 4.60 |
Income Statement
In the last 12 months, Progyny had revenue of $1.31 billion and earned $78.63 million in profits. Earnings per share was $0.91.
| Revenue | 1.31B |
| Gross Profit | 322.09M |
| Operating Income | 119.83M |
| Pretax Income | 119.84M |
| Net Income | 78.63M |
| EBITDA | 125.57M |
| EBIT | 119.83M |
| Earnings Per Share (EPS) | $0.91 |
Balance Sheet
The company has $236.93 million in cash and $26.97 million in debt, with a net cash position of $209.96 million or $2.74 per share.
| Cash & Cash Equivalents | 236.93M |
| Total Debt | 26.97M |
| Net Cash | 209.96M |
| Net Cash Per Share | $2.74 |
| Equity (Book Value) | 453.26M |
| Book Value Per Share | 5.90 |
| Working Capital | 272.93M |
Cash Flow
In the last 12 months, operating cash flow was $201.25 million and capital expenditures -$22.86 million, giving a free cash flow of $178.38 million.
| Operating Cash Flow | 201.25M |
| Capital Expenditures | -22.86M |
| Depreciation & Amortization | 5.74M |
| Net Borrowing | n/a |
| Free Cash Flow | 178.38M |
| FCF Per Share | $2.32 |
Margins
Gross margin is 24.57%, with operating and profit margins of 9.14% and 6.00%.
| Gross Margin | 24.57% |
| Operating Margin | 9.14% |
| Pretax Margin | 9.14% |
| Profit Margin | 6.00% |
| EBITDA Margin | 9.58% |
| EBIT Margin | 9.14% |
| FCF Margin | 13.61% |
Dividends & Yields
Progyny does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 4.01% |
| Shareholder Yield | 4.01% |
| Earnings Yield | 4.07% |
| FCF Yield | 9.22% |
Analyst Forecast
The average price target for Progyny is $34.42, which is 37.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $34.42 |
| Price Target Difference | 37.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 7.68% |
| EPS Growth Forecast (3Y) | 10.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Progyny has an Altman Z-Score of 7.63 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.63 |
| Piotroski F-Score | 6 |